tion and characterization of exendin-4,an exendin-3 analogue from Heloderma suspectum  venom. J Biol Chem . 1992; 267:7402-5. 8. Young A. Glucagon-like peptide-1, exen-din and insulin sensitivity. In: Hansen B, Shafrir E, eds. Insulin resistance and insu-lin resistance syndrome . New York: Har- wood Academic Press; 2002:235-62. 9. Chen YE, Drucker D. Tissue-specific ex- pression of unique mRNAs that encodepro-glucagon-derived peptides orexendin-4 in the lizard. J Biol Chem. 1997; 272:4108-15 10. Young AA, Gedulin BR, Bhavsar S et al. Glucose-lowering and insulin-sensitizingactions of exendin-4: studies in obese dia-betic (ob/ob, db/db) mice, diabetic fattyZucker rats, and diabetic rhesus monkeys(Macaca mulatta ). Diabetes.  1999; 48: 1026-34. 11. Egan JM, Clocquet AR, Elahi D. The in- sulinotropic effect of acute exendin-4administered to humans: comparison ofnondiabetic state to type 2 diabetes.  J Clin Endocrinol Metab . 2002; 87:1282- 90. 12. Parkes DG, Pittner R, Jodka C et al. In-